|Bid||0.9600 x 0|
|Ask||0.9800 x 0|
|Day's Range||0.9700 - 0.9900|
|52 Week Range||0.4300 - 1.2800|
|Beta (5Y Monthly)||2.41|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3rd \\- 6th, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.
LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops genetic analyzers for rapid pathogen detection, is pleased to announce that it will host a webcast investor presentation on Tuesday, July 14, at 2:00 PM ET. During the webcast, Dr. Jack Regan, LexaGene’s CEO and Founder, will provide an introductory presentation through a PowerPoint discussion that will cover key areas of LexaGene’s business, including an overview of the Company’s proprietary technology, target markets and opportunity, competitive advantages, growth strategy, and anticipated milestones. Following the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal.